- $3.66bn
- $3.53bn
- $1.66bn
- 84
- 41
- 59
- 64
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,249 | 1,229 | 1,805 | 2,001 | 1,662 |
Cost of Revenue | |||||
Gross Profit | 466 | 431 | 670 | 827 | 658 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,049 | 1,095 | 1,529 | 1,592 | 1,411 |
Operating Profit | 201 | 134 | 276 | 408 | 251 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 198 | 120 | 315 | 396 | 278 |
Provision for Income Taxes | |||||
Net Income After Taxes | 154 | 99.2 | 236 | 339 | 231 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 153 | 98.1 | 229 | 331 | 227 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 153 | 98.1 | 229 | 331 | 227 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.59 | 1.88 | 5 | 7.14 | 4.9 |